Feeds › Clinical trial updates
Clinical trial updates
Drug and device trials that companies register on ClinicalTrials.gov: newly completed phase 3 studies, changes of status and the dates a study is due to finish.
About this data
- What it is
- ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
- Who files it
- The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
- How current
- We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
- Terms
- ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
- Worth knowing
- A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
- Not to be confused with
- FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.
All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Studies updated per day, last 30 days
All industry-sponsored studies Sponsor matched to a public company
By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.
Latest clinical trial updates
Showing: ticker TNDM · All recent updates
Studies by the date their record was last updated.
| Updated | Study | SponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private. | PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages. | StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time). | Enrolled | Primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update. | Source |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France NCT07211126 · Diabetes Mellitus, Type 1 t:slim X2 insulin pump with Control-IQ technology (Control-… | TNDM Tandem Diabetes Care, Inc. | — | Recruiting | 350 | Dec 2027 | Registry ↗ |
| Sep 1, 2026 | PS230005 Control-IQ 1.5 Post-Approval Study NCT06717451 · Type 1 Diabetes Control-IQ Technology v1.5 | TNDM Tandem Diabetes Care, Inc. | — | Completed | 144 | Aug 10, 2026 | Registry ↗ |
| Aug 31, 2026 | Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type… NCT07325461 · Diabetes Mellitus, Type 1 SteadiSet Infusion Set | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 20 | Jun 24, 2026 | Registry ↗ |
| Jun 24, 2026 | Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study NCT05014789 · Diabetes Mellitus, Type 1 Control-IQ technology 2.0 | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 66 | Dec 20, 2021 | Registry ↗ |
| May 22, 2026 | A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes NCT05785832 · Type 2 Diabetes Treated With Insulin t:slim X2 insulin pump with Control-IQ+ technology and Dexc… | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 319 | Sep 24, 2024 | Registry ↗ |
| May 5, 2026 | Tandem Freedom - Feasibility Trial 2 NCT06834568 · Diabetes Mellitus, Type 1 t:slim X2 insulin pump with Tandem Freedom Algorithm | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 10 | Apr 7, 2025 | Registry ↗ |
| Nov 18, 2025 | Tandem Freedom Feasibility Study 1 NCT06428591 · Diabetes Mellitus, Type 1 t:slim X2 insulin pump with Tandem Freedom Algorithm | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 10 | Jun 10, 2024 | Registry ↗ |
| Sep 24, 2025 | Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes NCT06273124 · Type1diabetes SteadiSet Extended Wear Infusion Set | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 260 | Dec 11, 2024 | Registry ↗ |
| Apr 3, 2025 | Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ) NCT05422053 · Type 1 Diabetes t:slim X2 insulin pump with Control-IQ technology 1.5 | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 34 | Jan 6, 2023 | Registry ↗ |
| Dec 20, 2024 | Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes NCT05683392 · Type 1 Diabetes t:slim X2 insulin pump with Control-IQ technology 2.0 | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 72 | Dec 13, 2023 | Registry ↗ |
| Jul 26, 2024 | Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2… NCT05403502 · Type 1 Diabetes t:slim X2 insulin pump with Control-IQ technology 1.5 | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 183 | Aug 2, 2023 | Registry ↗ |
| Apr 5, 2024 | Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use NCT05204134 · Type 1 Diabetes Automated Insulin Delivery Settings Initialization and Adap… | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 33 | Sep 9, 2022 | Registry ↗ |
| Mar 6, 2024 | Control-IQ Technology in Individuals With Type 2 Diabetes NCT05111301 · Type 2 Diabetes Treated With Insulin Control-IQ technology 1.5 | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 30 | Aug 10, 2022 | Registry ↗ |
| Jan 11, 2024 | Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes NCT05973422 · Type 1 Diabetes SIGI Insulin Management System | TNDM Tandem Diabetes Care, Inc. | Not applicable | Unknown | 10 | Sep 30, 2024 | Registry ↗ |
| Dec 8, 2023 | Control-IQ Observational (CLIO) Post-Approval Study NCT04503174 · Diabetes Mellitus, Type 1 t:slim X2 pump with Control-IQ technology | TNDM Tandem Diabetes Care, Inc. | — | Completed | 3,157 | Jun 2, 2023 | Registry ↗ |
| Dec 8, 2023 | Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial NCT03195140 · Diabetes Mellitus, Type 1 Predictive Low Glucose Suspend | TNDM Tandem Diabetes Care, Inc. | Not applicable | Completed | 103 | Feb 6, 2018 | Registry ↗ |
| Sep 1, 2016 | Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study NCT02877771 · Diabetes Mellitus, Type 1 Diabetes t:slim insulin pump with predictive low glucose suspend | TNDM Tandem Diabetes Care, Inc. | Phase 1 | Completed | 10 | Aug 2016 | Registry ↗ |
17 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 9:12 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances